Pulmatrix
Trending Articles
Related Content
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
A novel platform for DP inhalation drugs
Novel dry powder delivery technologies have tremendous potential to enhance existing drugs and enable innovative products, particularly if these new delivery platforms can meet the needs of next generation inhaled drugs while overcoming the shortcomings of current approaches. Pulmatrix describes a novel inhaled dry powder (DP) delivery platform termed iSPERSE (inhaled small particles easily respirable and emittable) that offers the potential to effectively deliver a wide spectrum of drug molecules to patients.